Heart Disease in Cavalier King Charles Spaniels: An Owner's Guide

The breed and the disease

If you own a Cavalier King Charles Spaniel, or if you are considering bringing one into your life, there is one health reality you need to understand clearly: this breed and Myxomatous Mitral Valve Disease are deeply intertwined. More than any other breed, the Cavalier carries the burden of MMVD — not as a possibility but as a near-certainty.

This is not written to frighten you. It is written because understanding this reality is the foundation for giving your Cavalier the best life possible. Knowledge about the disease, combined with proactive screening and modern treatment, means that many Cavaliers with MMVD live long, happy, comfortable lives. But that outcome depends on being informed, being proactive, and working with veterinary professionals who understand the unique cardiac challenges of this remarkable breed.

Why Cavaliers are different

The numbers

The prevalence of MMVD in Cavalier King Charles Spaniels is staggering:

• By age 5, approximately 50 percent of Cavaliers have a detectable heart murmur indicating mitral valve degeneration.
• By age 10, the prevalence approaches nearly 100 percent. Virtually every Cavalier will develop some degree of MMVD if they live long enough.

Compare this to the general small-breed population, where MMVD prevalence reaches similar levels only in very elderly dogs — those over 13 to 16 years of age. Cavaliers develop the disease years earlier than other breeds, and the disease often progresses more rapidly.

The genetic basis

MMVD in Cavaliers is a heritable condition — meaning it is passed from parents to offspring through genetic factors. Research has demonstrated that the age of onset of MMVD in Cavaliers is strongly influenced by genetics. Dogs whose parents developed murmurs at a young age are significantly more likely to develop murmurs early themselves.

The inheritance pattern appears to be polygenic — involving multiple genes rather than a single mutation. This makes the genetics complex and means there is no simple genetic test that can predict whether an individual Cavalier will develop MMVD or when. The condition appears to involve genes affecting connective tissue integrity, valve development, and possibly inflammatory pathways.

What is clear from decades of research is that the Cavalier King Charles Spaniel breed, through its genetic history, carries a predisposition to premature mitral valve degeneration that is fundamentally different in degree from other affected breeds.

Earlier onset, not a different disease

It is important to understand that the MMVD seen in Cavaliers is the same disease that affects other small breeds — myxomatous degeneration of the mitral valve leaflets leading to progressive regurgitation. Cavaliers do not have a unique form of heart disease. What they have is the same disease appearing much earlier in life and, in many cases, progressing more aggressively than in other breeds.

This earlier onset means that:

• A Cavalier may develop significant heart disease during what should be the prime of life, not just in old age.
• There is more time for the disease to progress, since it starts earlier.
• Screening and monitoring must begin earlier than in other breeds.
• Treatment decisions may be needed at a younger age.

Screening: the cornerstone of Cavalier cardiac care

Because MMVD is so prevalent and often so early in onset, screening is not optional for Cavalier owners — it is essential. Early detection gives you the maximum advantage in managing the disease.

When to start

The current recommendation for Cavalier King Charles Spaniels is to begin cardiac screening significantly earlier than for other breeds:

• Annual echocardiography starting at age 1 is recommended by many veterinary cardiologists who specialize in the breed.
• At minimum, annual cardiac auscultation (stethoscope examination) should begin at the first veterinary visit and continue at every visit thereafter.
• Some Cavalier health advocates recommend a baseline echocardiogram at age 1, followed by annual echocardiography from age 3 onward, with earlier repeat echocardiography if a murmur is detected at any time.

What screening involves

• Auscultation — Your veterinarian listens to the heart with a stethoscope at every visit. In Cavaliers, even a very soft murmur (grade I or II) warrants follow-up echocardiography, given the high pre-test probability of MMVD.
• Echocardiography — A cardiac ultrasound performed by a veterinary cardiologist. This is the gold standard for diagnosing and staging MMVD. It measures valve structure, regurgitation severity, and chamber sizes — the information needed to determine whether your Cavalier is B1, B2, or beyond.
• Resting respiratory rate monitoring — Learn to count your Cavalier's breathing rate at rest or during sleep. A normal rate is 15 to 25 breaths per minute. Establishing this baseline early — long before any disease is detected — gives you the most sensitive early warning system available.

The cost of screening

Annual echocardiography is an investment, typically ranging from $300 to $600 per visit depending on your location and the cardiologist. For Cavalier owners, this should be considered a routine and expected expense of breed ownership, much like annual dental cleanings or vaccinations. The information gained from regular echocardiography can be the difference between catching Stage B2 at the right time and missing it entirely.

Key point: If you own a Cavalier King Charles Spaniel, annual cardiac screening by a veterinary cardiologist is one of the most important things you can do for your dog. It is not a luxury — it is a necessity given the breed's cardiac reality.

The MVD breeding protocol

In response to the extraordinary prevalence of MMVD in Cavaliers, breed health organizations have developed breeding protocols aimed at reducing the incidence and delaying the onset of the disease.

How the protocol works

The most widely recognized breeding protocol recommends that Cavalier King Charles Spaniels should not be bred unless they meet specific cardiac criteria:

• Dogs should be free of heart murmurs at the time of breeding.
• Both parents should have been clear of murmurs on annual cardiac examination until at least age 2.5 years (some protocols require clearance until age 5).
• Some advanced versions of the protocol require that the parents of the breeding dogs (the grandparents of the planned litter) also be clear of murmurs until specific ages.

The logic is straightforward: by only breeding dogs that are free of MMVD at older ages, you are selecting for the genetic factors associated with later onset — gradually pushing the average age of onset later with each generation.

Does it work?

Research supports the principle. Studies have demonstrated that selecting breeding dogs based on cardiac status can shift the age of onset of MMVD in offspring. However, compliance with the protocol across the breeding community has been inconsistent, and the impact on the overall breed population has been slower than hoped.

The protocol faces practical challenges:

• Many breeders do not comply. Whether due to lack of awareness, the cost of screening, or the desire to breed dogs with other desirable traits that happen to have early-onset murmurs, adherence to the protocol is far from universal.
• The polygenic nature of the disease makes progress slow. Unlike a simple recessive trait where carrier testing can rapidly reduce prevalence, polygenic conditions require sustained selection pressure over many generations.
• Small gene pool concerns — Cavaliers already have limited genetic diversity. Restricting breeding to only heart-clear dogs at older ages further narrows the gene pool, which can increase the prevalence of other genetic conditions.

What this means for you as a buyer

If you are looking for a Cavalier King Charles Spaniel puppy, cardiac screening of the parents is one of the most important questions to ask a breeder:

• Ask whether both parents have been screened by a veterinary cardiologist — not just a general practitioner — and whether they were clear of murmurs at the time of breeding.
• Ask the age of the parents at the time of their most recent cardiac clearance. Older clearances (age 5 or older) are more meaningful than clearances at age 2.
• Ask about the cardiac history of the grandparents if possible.
• Ask for documentation. Reputable breeders will have cardiac clearance certificates and be transparent about the cardiac health of their lines.

A breeder who dismisses these questions, claims cardiac screening is unnecessary, or does not screen their breeding dogs should be a significant red flag.

Key point: No breeding program can guarantee a MMVD-free Cavalier. The disease is too deeply embedded in the breed's genetics. But responsible breeders who follow cardiac screening protocols give their puppies the best statistical chance of later onset and slower progression.

When your Cavalier is diagnosed

Given the near-universal prevalence, there will likely come a day when your veterinarian detects a murmur or your cardiologist identifies early MMVD on echocardiogram. Here is what to expect at each stage, with specific considerations for Cavaliers.

Stage B1: murmur present, heart not enlarged

Your Cavalier has a murmur, and echocardiography confirms mitral regurgitation, but the heart chambers have not enlarged significantly. LA:Ao ratio is below 1.6, and LVIDdN is below 1.7.

For Cavaliers at B1:

• No cardiac medication is needed — The evidence does not support starting pimobendan before the heart enlarges, even in a breed as predisposed as the Cavalier.
• Monitor more frequently than in other breeds. Given the tendency for faster progression in Cavaliers, many cardiologists recommend echocardiographic rechecks every 6 months rather than annually.
• Begin daily resting respiratory rate monitoring if you have not already.
• Continue normal activity. Your Cavalier should run, play, and live joyfully. There are no restrictions.

Stage B2: heart has enlarged, treatment begins

The echocardiogram shows that the left atrium and left ventricle have enlarged (LA:Ao of 1.6 or greater, LVIDdN of 1.7 or greater). This is the critical threshold.

For Cavaliers at B2:

• Start pimobendan. The EPIC study — which included a significant number of Cavaliers — demonstrated that pimobendan at Stage B2 delays the onset of heart failure by a median of approximately 15 months. This benefit applies to Cavaliers as much as to any breed.
• Echocardiographic monitoring every 4 to 6 months.
• Continue resting respiratory rate monitoring daily.
• No activity restrictions unless your cardiologist advises otherwise.

Stage C: congestive heart failure

Heart failure has developed, with fluid accumulating in the lungs. Signs include increased breathing rate and effort, coughing, decreased energy, and in severe cases, respiratory distress.

For Cavaliers at C:

• Full medical management — Pimobendan, furosemide, ACE inhibitor (enalapril or benazepril), and spironolactone.
• Close monitoring — Frequent rechecks, daily respiratory rate monitoring, medication adjustments as needed.
• Activity guided by your dog's comfort — Let your Cavalier set the pace. Gentle walks and calm play are typically fine.

Prognosis: what to expect

The prognosis for a Cavalier with MMVD depends heavily on the stage at diagnosis and the individual dog's rate of progression.

The encouraging reality:

• Many Cavaliers are diagnosed with murmurs in their middle years and live comfortably for years before the disease progresses to a stage requiring treatment.
• With pimobendan started at B2, many Cavaliers have years of good-quality life ahead.
• Even after heart failure develops (Stage C), many Cavaliers respond well to medication and live 12 to 18 months or longer with good quality of life.
• Some Cavaliers live well into their teens — 13, 14, even 15 years — despite a diagnosis of MMVD in middle age.

The sobering reality:

• Some Cavaliers develop aggressive, rapidly progressive MMVD that leads to heart failure at a young age — sometimes as early as 5 to 7 years.
• Acute events — such as rupture of the chordae tendineae (the cords that anchor the valve) — can cause sudden, severe heart failure.
• Not all Cavaliers respond equally well to medication, and some will progress to Stage D despite optimal therapy.

The variability in outcomes underscores the importance of regular monitoring — it is the only way to know how your individual Cavalier's disease is behaving.

The emotional reality

Owning a breed that is virtually guaranteed to develop heart disease carries a unique emotional weight. It is worth acknowledging this openly, because it is something every Cavalier owner eventually confronts.

The anticipatory anxiety

Even before a murmur is detected, many Cavalier owners carry a quiet awareness that the diagnosis is coming. Every veterinary visit includes a moment of tension when the stethoscope is placed on the chest. Every echocardiogram appointment carries a mix of hope and dread.

This anticipatory anxiety is normal. It does not mean you are being melodramatic or overreacting. You are aware of a genuine statistical reality, and it is natural to feel apprehensive about it.

When the diagnosis comes

The moment the murmur is first heard — or the echocardiogram first shows changes — can feel devastating, even if you knew it was likely. The abstract knowledge that "Cavaliers get heart disease" becomes suddenly, personally real when it is your Cavalier, your companion, your heart dog.

Allow yourself to feel whatever you feel. Then take the next step: schedule the echocardiogram, learn the stage, understand the plan. The transition from fear to knowledge to action is the path forward.

The daily counting

Resting respiratory rate monitoring becomes a daily ritual for Cavalier owners. And while it is medically invaluable, it can also be emotionally taxing — a constant reminder that your dog has a progressive disease. Some owners find it helps to reframe the counting as an act of love and care rather than an act of worry. You are doing something concrete and meaningful for your dog's health. That matters.

Finding your community

You are not alone in this. Cavalier King Charles Spaniel communities — both online and in person — are filled with owners navigating the same cardiac journey. Connecting with others who understand the specific experience of loving a breed predisposed to heart disease can be genuinely therapeutic.

Organizations like the Cavalier King Charles Spaniel Club and breed-specific health foundations provide resources, support, and the latest research information.

What to look for in a breeder

If you are considering adding a Cavalier to your family, choosing a responsible breeder is the single most impactful decision you can make for your future dog's cardiac health.

Look for breeders who:

• Screen all breeding dogs with annual echocardiography by a board-certified veterinary cardiologist — not just a general practitioner listening with a stethoscope.
• Follow the MVD breeding protocol and can provide documentation of cardiac clearances.
• Are transparent about the cardiac history of their lines — including which dogs developed murmurs and at what ages.
• Do not breed dogs with murmurs before the recommended minimum age of clearance.
• Are involved in breed health organizations and support cardiac research.
• Will discuss MMVD openly and honestly rather than downplaying or denying the breed's cardiac challenges.

Be cautious of breeders who:

• Do not perform cardiac screening or claim it is unnecessary.
• Breed young dogs without cardiac clearances.
• Dismiss questions about heart disease or become defensive.
• Claim their lines are "heart-clear" without providing veterinary documentation.
• Prioritize appearance, show wins, or other traits over health screening.

No breeder can promise a Cavalier that will never develop MMVD. But breeders who screen diligently and breed responsibly give their puppies the best possible start.

A note on other Cavalier health concerns

While MMVD is the most significant health concern in the breed, Cavaliers are also predisposed to several other conditions:

• Syringomyelia (SM) — A serious neurological condition related to skull malformation (Chiari-like malformation). Responsible breeders screen for this with MRI.
• Episodic falling syndrome — A neurological condition causing episodes of muscle stiffness and collapse. Genetic testing is available.
• Dry eye and curly coat syndrome — A genetic condition with available testing.
• Hip dysplasia and patellar luxation — Joint conditions that can be screened for.

Comprehensive health testing — not just cardiac screening — is the hallmark of a responsible Cavalier breeder.

The bottom line

The Cavalier King Charles Spaniel is one of the most beloved, affectionate, and gentle breeds in the world. Their temperament is extraordinary — endlessly loving, remarkably intuitive, and deeply devoted to their people. There is a reason Cavalier owners are passionate about the breed, and there is a reason many come back to the breed again and again, despite knowing the cardiac challenges.

Here is what every Cavalier owner and prospective owner should know:

• MMVD will likely affect your Cavalier. Nearly 100 percent of Cavaliers develop the disease by age 10, with many showing signs by age 5. This is the breed's reality.
• Early and regular screening is essential. Annual echocardiography starting at age 1 gives you the best chance of catching the disease early and intervening at the right time.
• The MVD breeding protocol matters. Choosing a breeder who screens and follows the protocol gives your puppy the best statistical chance of later onset.
• Treatment works. The EPIC study showed that pimobendan at Stage B2 delays heart failure by approximately 15 months. Combined with diligent monitoring and staged medication, many Cavaliers live long, full lives despite their diagnosis.
• Prognosis is often better than you fear. Many Cavaliers live well into their teens with proper cardiac management. A diagnosis of MMVD, while sobering, is not a death sentence.
• You are not alone. The Cavalier community is large, supportive, and experienced in navigating cardiac disease. Lean on it.

Loving a Cavalier means loving a dog whose heart may be vulnerable — in more ways than one. But it also means experiencing a depth of companionship that is truly special. The disease is real, but so is the joy. And with modern veterinary cardiology, attentive ownership, and a good cardiologist by your side, there is every reason to be hopeful about the years ahead.